(Reuters) -Italian hearing aid group Amplifon reported a 27.7% drop in its third-quarter adjusted net profit to 19.2 million euros ($22.4 million) on Wednesday.
The company confirmed the 2025 guidance it had already lowered in July.
CONTEXT
Amplifon said it saw a material improvement in revenue trend in the third quarter, with a return to organic growth and stronger performance in Europe and the Americas despite market growth below historical levels.
The company is under pressure to regain business momentum and show that its investments in digital innovation and AI tools can close the gap with faster-growing peers like Switzerland’s Sonova.
Amplifon is among the first hearing aid firms in Europe to report its quarterly results. Sonova and Denmark-based Demant and GN Store Nord will report their earnings in November.
WHY IT’S IMPORTANT
The group said its Fit4Growth programme, launched in July, now includes aims for a 150–200 basis point adjusted EBITDA margin improvement by 2027, with the group closing and consolidating around 100 non-performing clinics across different markets.
BY THE NUMBERS
Revenue for the third quarter stood at 563.3 million euros, down 0.7% compared to the same period in 2024, while adjusted EBITDA for the period was 107.3 million euros, down 6.3% less than Q3 2024.
The company reported debt at September-end of 1.18 billion euros.
WHAT’S NEXT
Amplifon expects 2025 revenue growth of 2–2.5% at constant exchange rates and an adjusted EBITDA margin around 23%, factoring in a 50 basis point impact from network optimisation under Fit4Growth.
KEY QUOTES
“The performance was driven by a significant acceleration in Europe, also thanks to an improvement in Italy and Spain and despite a lower contribution from France compared to the previous quarter, as well as above-market growth in the Americas,” CEO Enrico Vita said.
($1 = 0.8575 euros)
(Reporting by Laura Contemori; Editing by Milla Nissi-Prussak and Matt Scuffham)
